CAS No. 18022-52-1

3,4-Pentadien-1-ol, 3-methyl-

Catalog No.: 628006
Name: 3,4-Pentadien-1-ol, 3-methyl-
CAS: 18022-52-1
Formula: C6H10O

Inquire about this product → | Safety data

About 3,4-Pentadien-1-ol, 3-methyl-

3,4-Pentadien-1-ol, 3-methyl- is a chemical compound registered under CAS number 18022-52-1, with the molecular formula C6H10O and a molecular weight of about 98.14 g/mol. 9CMX supplies 3,4-Pentadien-1-ol, 3-methyl- for laboratory research and bulk production; product code 628006. Send an inquiry for purity, packaging, price and lead time.

CAS Number: 18022-52-1
Molecular Formula: C6H10O
Molecular Weight: 98.14 g/mol

Related Keywords

pentadien

2-Anthracenamine, N-octyl-9,10-bis(phenylethynyl)-

2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-5-phenyl-, 4-oxide

2H-1,4a-Ethanonaphthalen-1(5H)-ol, 3,4,6,7-tetrahydro-, acetate

2H-1,3-Thiazine-2-thione, 3-(diphenylacetyl)tetrahydro-

1-[2-Amino-5-(4-hydroxypiperidin-1-yl)phenyl]ethan-1-one

1H-Imidazole-5-carboxaldehyde,1-methyl-2-[[(4-nitrophenyl)methyl]thio]-

753019-89-5

Heptanoic acid, 7-oxo-7-[(phenylmethyl)amino]-, phenylmethyl ester

S-[3-({4-[2-(propan-2-yl)phenoxy]butyl}amino)propyl] hydrogen sulfurothioate

2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-5-(3-methylphenyl)-

Spiro[cyclohexane-1,9'-[9H]fluorene], 2',7'-di-1-pyrenyl-

4-(3-bromo-phenylamino)-3-nitro-benzonitrile

2H-1,4,8-Thiadiazecin-6-ol,5,6,7,10-tetrahydro-2,2,6,10,10-pentamethyl-

64002-47-7

2H-1,4-Benzodiazepin-2-one,1,3,4,5-tetrahydro-1-[2-(2-methoxyphenyl)ethyl]-3-(1-methylethyl)-7-propoxy-, (3S)-

2H-1,4-Benzodiazepin-2-one,3-[[1-[(4-chlorophenyl)methyl]-1H-indol-3-yl]methyl]-5-(2-fluorophenyl)-1,3-dihydro-1-methyl-, (R)-

2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-5-methyl-3-propyl-, (3S)-

28-(1H-Imidazol-1-yl)-3,12,28-trioxooleana-1,9(11)-diene-2-carbonitrile

2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-iodo-5-phenyl-

2H-1,4-Benzodiazepin-2-one,5-(2-fluorophenyl)-1,3-dihydro-3-(1H-indol-3-ylmethyl)-, (3S)-

103343-02-8

1H-Pyrrolo[3,4-c]quinoline-8-sulfonamide,2-[2-(acetyloxy)ethyl]-2,3-dihydro-4-methyl-N-(1-methylethyl)-1,3-dioxo-

2H-1,4-Benzodiazepin-2-one, 7-chloro-3-ethyl-1,3-dihydro-5-phenyl-

2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, diazotized, coupled with diazotized 2-amino-4,6-dinitrophenol, diazotized 4-nitrobenzenamine and resorcinol

L-Cysteine,S-[[4'-(1H-indol-1-yl)[1,1'-biphenyl]-4-yl]methyl]-N-(phenylacetyl)-

2(1H)-PYRIDINONE, 5-[(4-FLUOROPHENYL)METHYL]-

2H-1,4-Benzodiazepin-2-one,1,3-dihydro-3-(hydroxy-1H-indol-3-ylmethyl)-1-methyl-5-phenyl-

103343-15-3

5,8,14-Trioxa-2,11-diazahexadecanoic acid,16-[(2,5-dioxo-1-pyrrolidinyl)oxy]-12,16-dioxo-, 1,1-dimethylethyl ester

2H-1,4-Benzodiazepin-2-one,3-[(3-bromophenyl)hydroxymethyl]-1-ethyl-1,3-dihydro-7,8-dimethoxy-5-phenyl-

2,7-Naphthalenedisulfonic acid,3,4-dihydro-4-oxo-3-(phenylhydrazono)-, disodium salt

Diselenide, bis(2,4,6-triethylphenyl)

2,7-Naphthalenedicarboxylic acid, 3-hydroxy-, 7-butyl ester

2,7-Dioxa-6-azabicyclo[2.2.1]hept-5-ene, 4-methoxy-3-methyl-,(1R,3S,4S)-rel-

496878-25-2

2,7-Naphthalenedisulfonic acid,3-[[4,6-bis[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-5-hydroxy-

2H-1,4-Benzodiazepin-2-one,1,3-dihydro-7,8-dimethoxy-5-(6-methoxy-2-naphthalenyl)-1-methyl-

4-((benzyloxy)carbonyl)-2-fluorobenzoic acid

2,5-Cyclohexadien-1-one,4-[(4-iodophenyl)imino]-2,6-bis(1-methylethyl)-

2H-1,4-Benzodiazepin-2-one,1,3-dihydro-5-phenyl-3-[[[2-(trifluoromethyl)phenyl]methyl]amino]-

2H-1,4-Benzodiazepin-2-one,1,3-dihydro-7,8-dimethoxy-1-methyl-5-(4-pyridinyl)-